Biocon Biologics
Nabil Mohammed K.K is a Principal Scientist at Biocon Biologics, with a strong background in Early-stage development of biosimilar antibodies. Prior to this, Nabil worked as a Research Associate at Dr. Reddy's Laboratories, focusing on analytical similarity assessment of biosimilar monoclonal antibodies. Nabil also has experience as a Research Executive at Pfizer, where they implemented analytical methods for quantitation of quality attributes in bio-similar monoclonal antibodies. With a Master's in Biotechnology from Vellore Institute of Technology, Nabil has a solid educational background to support their extensive work experience in the biopharmaceutical industry.
This person is not in the org chart
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics